Literature DB >> 32814017

Major Lipids and Future Risk of Pneumonia: 20-Year Observation of the Atherosclerosis Risk in Communities (ARIC) Study Cohort.

Sangmee Sharon Bae1, L Cindy Chang2, Sharon Stein Merkin3, David Elashoff4, Junichi Ishigami5, Kunihiro Matsushita5, Christina Charles-Schoeman6.   

Abstract

BACKGROUND: Circulating lipids have been implicated as important modulators of immune response, and altered lipid levels correlate with the severity of infection. However, long-term prognostic implications of lipid levels regarding future infection risk remain unclear. The current project aims to explore whether baseline lipid levels are associated with risk of future serious infection, measured by hospitalization for pneumonia.
METHODS: A retrospective analysis was performed in 13,478 participants selected from the Atherosclerosis Risk in Communities (ARIC) study, a large community-based longitudinal cohort in the United States with a median follow-up time of >20 years. First incident of hospitalization for pneumonia was identified through hospital discharge records. Cox proportional hazard models were used to assess the association of baseline major lipid levels (total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], triglycerides) with time to first pneumonia hospitalization.
RESULTS: A total of 1969 (14.61%) participants had a pneumonia hospitalization during a median follow-up time of 21.5 years. The hazard ratio (HR) for pneumonia hospitalization was 0.90 (95% confidence interval, 0.87-0.92) for every 10-mg/dL increase in baseline HDL-C, and 1.02 (95% confidence interval, 1.02-1.03) for every 10-mg/dL increase in baseline triglycerides. HDL-C and triglycerides both remained significant predictors of pneumonia hospitalization after multivariable adjustment. Such associations were not seen with baseline LDL-C or total cholesterol levels.
CONCLUSION: Lower baseline HDL-C and higher triglyceride levels were strongly associated with increased risk of long-term pneumonia hospitalization in a large longitudinal US cohort.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARIC cohort; Lipids; Observational cohort; Pneumonia

Mesh:

Substances:

Year:  2020        PMID: 32814017      PMCID: PMC7870521          DOI: 10.1016/j.amjmed.2020.07.022

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  39 in total

Review 1.  Plasma lipoproteins are important components of the immune system.

Authors:  Runlin Han
Journal:  Microbiol Immunol       Date:  2010-04       Impact factor: 1.955

Review 2.  Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins.

Authors:  Satoshi Imaizumi; Mohamad Navab; Cecilia Morgantini; Christina Charles-Schoeman; Feng Su; Feng Gao; Murray Kwon; Ekambaram Ganapathy; David Meriwether; Robin Farias-Eisner; Alan M Fogelman; Srinivasa T Reddy
Journal:  Circ J       Date:  2011-05-28       Impact factor: 2.993

3.  Serum lipids in infection.

Authors:  J I Gallin; D Kaye; W M O'Leary
Journal:  N Engl J Med       Date:  1969-11-13       Impact factor: 91.245

Review 4.  The role of high-density lipoprotein in inflammation.

Authors:  Mohamad Navab; G M Anantharamaiah; Alan M Fogelman
Journal:  Trends Cardiovasc Med       Date:  2005-05       Impact factor: 6.677

5.  Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission.

Authors:  Yu-Fen Chien; Chung-Yu Chen; Chia-Lin Hsu; Kuan-Yu Chen; Chong-Jen Yu
Journal:  J Crit Care       Date:  2015-01-08       Impact factor: 3.425

6.  LDL and HDL enriched in triglyceride promote abnormal cholesterol transport.

Authors:  Josephine W Skeggs; Richard E Morton
Journal:  J Lipid Res       Date:  2002-08       Impact factor: 5.922

7.  Lipoprotein metabolism in patients with severe sepsis.

Authors:  Henk J van Leeuwen; Eric C J M Heezius; Geesje M Dallinga; Jos A G van Strijp; Jan Verhoef; Kok P M van Kessel
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

8.  Changes in serum lipoprotein pattern induced by acute infections.

Authors:  K Sammalkorpi; V Valtonen; Y Kerttula; E Nikkilä; M R Taskinen
Journal:  Metabolism       Date:  1988-09       Impact factor: 8.694

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

Review 10.  HDL in innate and adaptive immunity.

Authors:  Alberico Luigi Catapano; Angela Pirillo; Fabrizia Bonacina; Giuseppe Danilo Norata
Journal:  Cardiovasc Res       Date:  2014-06-15       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.